Bicara Therapeutics CEO Sold Over 8,000 Company Shares. Is the Stock a Sell or Buy?

CEO Claire Mazumdar sold 8,234 common shares for ~$154,000 between March 4 and March 6, 2026, at a weighted average price around $18.74 per share. The transaction represented 2.37% of Mazumdar's direct common stock holdings, reducing direct ownership to 339,392 shares.